Valeant Pharmaceuticals Slashes Revenue, Earnings Guidance
Valeant Pharmaceuticals International Inc. on Wednesday cut its revenue and profit guidance for the fourth quarter and the full year, ahead of its meeting with investors.
Posted On Dec 17 2015